Trevicta 350 mg prolonged release suspension for injection
Prolonged release suspension for injection
registration number
50/2.6.5/0701
What Trevicta 350 mg prolonged release suspension for injection contains
paliperidone palmitate.
other ingredients
Citric acid monohydrate
Polyethylene glycol 4000
Polysorbate 20
Sodium dihydrogen phosphate monohydrate
Sodium hydroxide (for pH adjustment)
Water for injection.
Therapeutic classification
A.2.6.5 Central nervous system depressants.